S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Global shares trade mixed following technology selloff on Wall Street
The Real Problem With "Made in America" Lithium (Ad)
What is a Growth Stock Mutual Fund?
Sprinklr Gets Targets Raised By Analysts, Here's Why
The Real Problem With "Made in America" Lithium (Ad)
10 Best Airline Stocks to Buy
Ollie’s Bargain Outlet Goes On Sale 
New "Mined in America" Lithium Opportunities? (Ad)
Will MicroVision Maintain Its Momentum After the Short Squeeze?
Apple Partnership Strengthens Unity Software's Investment Appeal
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Global shares trade mixed following technology selloff on Wall Street
The Real Problem With "Made in America" Lithium (Ad)
What is a Growth Stock Mutual Fund?
Sprinklr Gets Targets Raised By Analysts, Here's Why
The Real Problem With "Made in America" Lithium (Ad)
10 Best Airline Stocks to Buy
Ollie’s Bargain Outlet Goes On Sale 
New "Mined in America" Lithium Opportunities? (Ad)
Will MicroVision Maintain Its Momentum After the Short Squeeze?
Apple Partnership Strengthens Unity Software's Investment Appeal
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Global shares trade mixed following technology selloff on Wall Street
The Real Problem With "Made in America" Lithium (Ad)
What is a Growth Stock Mutual Fund?
Sprinklr Gets Targets Raised By Analysts, Here's Why
The Real Problem With "Made in America" Lithium (Ad)
10 Best Airline Stocks to Buy
Ollie’s Bargain Outlet Goes On Sale 
New "Mined in America" Lithium Opportunities? (Ad)
Will MicroVision Maintain Its Momentum After the Short Squeeze?
Apple Partnership Strengthens Unity Software's Investment Appeal
S&P 500   4,267.52
DOW   33,665.02
QQQ   348.82
Stock market today: Global shares trade mixed following technology selloff on Wall Street
The Real Problem With "Made in America" Lithium (Ad)
What is a Growth Stock Mutual Fund?
Sprinklr Gets Targets Raised By Analysts, Here's Why
The Real Problem With "Made in America" Lithium (Ad)
10 Best Airline Stocks to Buy
Ollie’s Bargain Outlet Goes On Sale 
New "Mined in America" Lithium Opportunities? (Ad)
Will MicroVision Maintain Its Momentum After the Short Squeeze?
Apple Partnership Strengthens Unity Software's Investment Appeal
NASDAQ:HQY

HealthEquity (HQY) Stock Forecast, Price & News

$65.38
-0.29 (-0.44%)
(As of 06/7/2023 ET)
Compare
Today's Range
$64.74
$66.94
50-Day Range
$51.02
$65.67
52-Week Range
$48.86
$79.20
Volume
992,972 shs
Average Volume
559,991 shs
Market Capitalization
$5.59 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$80.91

HealthEquity MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.78 Rating Score
Upside/​Downside
25.9% Upside
$82.33 Price Target
Short Interest
Bearish
3.88% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.37mentions of HealthEquity in the last 14 days
Based on 30 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
50.98%
From $1.02 to $1.54 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Medical Sector

251st out of 981 stocks

Business Services, Not Elsewhere Classified Industry

41st out of 90 stocks


HQY stock logo

About HealthEquity (NASDAQ:HQY) Stock

HealthEquity, Inc. engages in the provision of technology-enabled services for healthcare and spending decisions. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.

Receive HQY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter.

HQY Stock News Headlines

SVB Securities Keeps Their Buy Rating on Healthequity (HQY)
BREAKING: Tiny biotech successfully treats blindness
There's a tiny biotech in Cambridge that's using a breakthrough technology to treat blindness. This company has already shown success in human trials... And Our research shows that anyone who gets in today could see a 46,751% return.
Why HealthEquity Stock Is Up Today
Why Shares of HealthEquity Are Up Tuesday
The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
Recap: HealthEquity Q1 Earnings
HealthEquity (HQY) Set to Announce Earnings on Monday
Earnings Preview For HealthEquity
Analysts Set HealthEquity, Inc. (NASDAQ:HQY) PT at $80.91
See More Headlines

HQY Price History

HQY Company Calendar

Last Earnings
3/21/2023
Today
6/08/2023
Next Earnings (Estimated)
9/05/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:HQY
Employees
3,208
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$82.33
High Stock Price Forecast
$94.00
Low Stock Price Forecast
$71.00
Forecasted Upside/Downside
+23.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.78
Research Coverage
8 Analysts

Profitability

Net Income
$-26,140,000.00
Pretax Margin
-1.11%

Debt

Sales & Book Value

Annual Sales
$861.75 million
Cash Flow
$2.70 per share
Book Value
$22.45 per share

Miscellaneous

Free Float
83,162,000
Market Cap
$5.59 billion
Optionable
Optionable
Beta
0.78

Key Executives

  • Jon KesslerJon Kessler
    President, Chief Executive Officer & Director
  • Angelique Hill
    Executive Vice President-Operations
  • Tyson Murdock
    Chief Financial Officer & Executive Vice President
  • Elimelech Rosner
    Chief Technology Officer & Executive VP
  • Jody Dietel
    Senior Vice President-Compliance & Regulatory News













HQY Stock - Frequently Asked Questions

Should I buy or sell HealthEquity stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" HQY shares.
View HQY analyst ratings
or view top-rated stocks.

What is HealthEquity's stock price forecast for 2023?

8 brokerages have issued 12-month target prices for HealthEquity's stock. Their HQY share price forecasts range from $71.00 to $94.00. On average, they predict the company's share price to reach $82.33 in the next twelve months. This suggests a possible upside of 25.9% from the stock's current price.
View analysts price targets for HQY
or view top-rated stocks among Wall Street analysts.

How have HQY shares performed in 2023?

HealthEquity's stock was trading at $61.64 on January 1st, 2023. Since then, HQY shares have increased by 6.1% and is now trading at $65.38.
View the best growth stocks for 2023 here
.

When is HealthEquity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, September 5th 2023.
View our HQY earnings forecast
.

How were HealthEquity's earnings last quarter?

HealthEquity, Inc. (NASDAQ:HQY) released its quarterly earnings data on Tuesday, March, 21st. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.06. The business had revenue of $233.84 million for the quarter, compared to the consensus estimate of $229.43 million. HealthEquity had a positive trailing twelve-month return on equity of 4.30% and a negative net margin of 0.93%.

What guidance has HealthEquity issued on next quarter's earnings?

HealthEquity issued an update on its FY 2024 earnings guidance on Wednesday, June, 7th. The company provided earnings per share (EPS) guidance of $1.88-$1.97 for the period, compared to the consensus EPS estimate of $1.77. The company issued revenue guidance of $975.00 million-$985.00 million, compared to the consensus revenue estimate of $967.94 million.

What is Jon Kessler's approval rating as HealthEquity's CEO?

359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend.

What other stocks do shareholders of HealthEquity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP).

What is HealthEquity's stock symbol?

HealthEquity trades on the NASDAQ under the ticker symbol "HQY."

Who are HealthEquity's major shareholders?

HealthEquity's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.13%), Wasatch Advisors LP (9.10%), FMR LLC (5.34%), William Blair Investment Management LLC (3.39%), State Street Corp (3.24%) and JPMorgan Chase & Co. (2.90%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker and William Robert Otten.
View institutional ownership trends
.

How do I buy shares of HealthEquity?

Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is HealthEquity's stock price today?

One share of HQY stock can currently be purchased for approximately $65.38.

How much money does HealthEquity make?

HealthEquity (NASDAQ:HQY) has a market capitalization of $5.59 billion and generates $861.75 million in revenue each year. The company earns $-26,140,000.00 in net income (profit) each year or ($0.10) on an earnings per share basis.

How many employees does HealthEquity have?

The company employs 3,208 workers across the globe.

How can I contact HealthEquity?

HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The official website for the company is www.healthequity.com. The company can be reached via phone at (801) 727-1000, via email at rputnam@healthequity.com, or via fax at 801-727-1005.

This page (NASDAQ:HQY) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -